FindMyRecallSubscribe
Class I: serious health riskOngoing

Botanical Be Reumo Flex caplets Recall

Reumo Flex caplets, packaged in 30-count boxes, Manufactured by: Grupo Yepenza de Mexic…

Botanical Be · El Paso, TX

Risk level
Class I
Reported by FDA
Dec 6, 2023
Recall ID
D-0225-2024
Check your lot numberHow we source this data

Summary

Botanical Be recalled Reumo Flex caplets starting Oct 20, 2023. The FDA classified it as Class I (serious health risk) and published enforcement report D-0225-2024 on Dec 6, 2023. Reason: Marketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac. Status: Ongoing.

Why it was recalled

Marketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.

Product description

Reumo Flex caplets, packaged in 30-count boxes, Manufactured by: Grupo Yepenza de Mexico, SA de CV, Comerciantes 5824 Col Arcos de Guadalupe, Zapopan Jal Mexico, UPC 7 502214 014598

Lot numbers, UPCs & expiration codes

All lots, exp 10/20/2024

Where it was sold

USA Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0225-2024
Classification
Class I
Status
Ongoing
Recall initiated
Oct 20, 2023
FDA report date
Dec 6, 2023
Recall type
Voluntary: Firm initiated
Recalling firm
Botanical Be

Original FDA data

Every field from FDA enforcement report D-0225-2024, exactly as published.

Show all FDA fields
City
El Paso
State
TX
Status
Ongoing
Country
United States
Event ID
93257
Address
360 Jardin Bello
Code information
All lots, exp 10/20/2024
Postal code
79932-2357
Report date
Dec 6, 2023
Product type
Drugs
Recall number
D-0225-2024
Classification
Class I
Recalling firm
Botanical Be
Reason for recall
Marketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Reumo Flex caplets, packaged in 30-count boxes, Manufactured by: Grupo Yepenza de Mexico, SA de CV, Comerciantes 5824 Col Arcos de Guadalupe, Zapopan Jal Mexico, UPC 7 502214 014598
Distribution pattern
USA Nationwide
Recall initiation date
Oct 20, 2023
Initial firm notification
Telephone
Center classification date
Jan 12, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0225-2024, published Dec 6, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls